has been cited by the following article(s):
|
[1]
|
Cardiovascular risk scores, non-invasive vascular measures and myositis damage index reveal increased cardiovascular risk in idiopathic inflammatory myopathies: a case-control study
BMC Rheumatology,
2026
DOI:10.1186/s41927-026-00633-z
|
|
|
|
|
[2]
|
Safety of Atorvastatin in Patients With Stable Systemic Autoimmune Myopathies
JCR: Journal of Clinical Rheumatology,
2021
DOI:10.1097/RHU.0000000000001276
|
|
|
|
|
[3]
|
Vasculometabolic effects in patients with congenital growth hormone deficiency with and without GH replacement therapy during adulthood
Pituitary,
2021
DOI:10.1007/s11102-020-01099-z
|
|
|
|